The results here obtained using antagonists (GW9662 and GGPP) and by knocking down LXRα confirmed that increased expression of LXRα was associated with higher sensitivity of lung adenocarcinoma cell proliferation inhibition 29. The gene discussed is NR1H3; the disease is lung adenocarcinoma.